MetaboGen is a leading brand in the field of metagenome research and development. Founded in 2011, MetaboGen was established with the aim of providing commercial access to breakthrough science in the microbiome field. Collaborating with renowned experts, Professor Fredrik Bäckhed from the University of Gothenburg and Professor Jens B Nielsen from Chalmers University of Technology, the company strives to revolutionize the pharmaceutical and probiotics industries.

MetaboGen's cutting-edge platform technology enables the creation of next-generation probiotics and pharmaceutical products. By harnessing the power of the microbiome, they are paving the way for innovative solutions that have the potential to transform healthcare. As a wholly owned daughter company of BioGaia AB, MetaboGen benefits from extensive knowledge and expertise in the field.

With a strong focus on research and development, MetaboGen is committed to pushing boundaries and bringing groundbreaking products to market. They offer a comprehensive range of services to industry partners, facilitating the development of personalized healthcare solutions. Contact MetaboGen today to explore the endless possibilities of metagenome research for a healthier future